Ingevity Corporation (NGVT) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and Ingevity published the results on November 4, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Ingevity reports EPS two ways: GAAP, under the accounting rules every US filer follows, and diluted adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• EPS shown is diluted EPS from continuing operations, the figure Ingevity leads with. Including discontinued operations (the industrial specialties product line sold on January 1, 2026), diluted EPS was $1.41, against $1.18. Net income shown includes discontinued operations.
• Ingevity sold its Road Markings product line on April 15, 2026. It contributed $35.0 million of Pavement Technologies net sales in Q3 2025 and none in Q3 2026. Pavement Technologies is the renamed Performance Chemicals segment.

Source: Ingevity Q3 2026 results, November 4, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Ingevity splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Ingevity's Performance Materials revenue was $154 million in Q3 2026, down 1% from $155 million in Q3 2025, 51% of total revenue.
• Ingevity's Pavement Technologies revenue was $106 million in Q3 2026, down 24% from $140 million in Q3 2025, 35% of total revenue.
• Ingevity's Advanced Polymer Technologies revenue was $45.0 million in Q3 2026, up 18% from $38.2 million in Q3 2025, 15% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, Ingevity said:

“Following solid third-quarter results, the company is narrowing its full-year 2026 adjusted EBITDA outlook to a range of $385 million to $395 million, maintaining the midpoint of the prior range.”

“The company expects full-year net sales of approximately $1.1 billion and diluted adjusted EPS of $5.25 to $5.45.”

“Free cash flow is now expected to be between $220 million and $230 million, excluding the second quarter $113.2 million litigation settlement payment, reflecting increased capital expenditures and working capital investments as the company enters 2027.”

Source: Ingevity Q3 2026 release, Nov 4, 2026.

This is the company's own guidance as of Nov 4, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the NGVT forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

Net sales and diluted EPS from continuing operations, each as first reported in that quarter's release. The Q4 2025 loss came mainly from non-cash special charges related to Advanced Polymer Technologies and Road Markings.

We do not hold a confirmed date for Ingevity's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 4, 2026

Ingevity reports three segments. Performance Materials, which makes activated carbon for automotive emissions control and filtration, had Q3 2026 net sales of $154.1 million, about half of the $305.1 million total and nearly flat from $155.0 million. Pavement Technologies had $106.0 million, down 24%, and Advanced Polymer Technologies $45.0 million, up 18%. (Ingevity Q3 2026 release, Nov 4, 2026)

Total net sales fell 8%, mainly because Ingevity sold its Road Markings product line on April 15, 2026; Road Markings had brought in $35.0 million in Q3 2025. Excluding Road Markings, Ingevity said sales rose 2%. In Pavement Technologies, higher prices offset softer demand, which Ingevity tied to persistently higher asphalt costs driven by crude oil inflation. (Ingevity Q3 2026 release, Nov 4, 2026; Ingevity Form 10-Q, Q3 2026, Nov 5, 2026)

In Performance Materials, Ingevity said resilient North American demand, helped by consumer preference for hybrid vehicles, and higher non-auto filtration sales offset lower volumes in automotive applications in China and Europe. Its automotive customer base is concentrated: Ingevity sells automotive technology products to about 65 customers, and its ten largest accounted for about 90 percent of those sales in 2025. (Ingevity Q3 2026 release, Nov 4, 2026; Ingevity Form 10-K, 2025, Feb 26, 2026)

Advanced Polymer Technologies' 18% increase came from higher pricing, including a price surcharge to offset higher input costs, and a mix shift toward higher-value derivative products. Ingevity is running a sale process for the segment and said an announced agreement may extend into early 2027. (Ingevity Q3 2026 release, Nov 4, 2026)

Ingevity's diluted EPS from continuing operations rose to $1.46 in Q3 2026 from $1.10. Net interest expense fell to $13.5 million from $18.4 million, the effective tax rate was 25.8% against 34.4%, and diluted shares fell to 34.9 million from 37.0 million. (Ingevity Q3 2026 release, Nov 4, 2026; Ingevity Form 10-Q, Q3 2026, Nov 5, 2026)

Diluted adjusted EPS of $1.63 adds back a $0.09 loss on the sale of a business, $0.04 of portfolio realignment costs, $0.01 of restructuring and a $0.06 discrete tax provision, less $0.03 of tax effect on those items. (Ingevity Q3 2026 release, Nov 4, 2026)

Ingevity bought back about $39 million of shares in Q3 2026 at a weighted average price of $71.45, bringing 2026 repurchases to about $125 million, with about $172 million left on its authorization. Net leverage was 2.5 times, against 2.7 times a year earlier. (Ingevity Q3 2026 release, Nov 4, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Ingevity gives a full-year outlook in its release. With Q3 2026 results it narrowed 2026 adjusted EBITDA guidance to $385 million to $395 million, keeping the midpoint, and guided net sales of about $1.1 billion and diluted adjusted EPS of $5.25 to $5.45. It expects free cash flow of $220 million to $230 million, excluding a $113.2 million litigation settlement paid in the second quarter. The outlook includes Advanced Polymer Technologies for the full year and excludes Road Markings after April 15. (Ingevity Q3 2026 release, Nov 4, 2026)

A consensus figure is the average of the models published by the analysts who cover Ingevity, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Ingevity's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning NGVT is on is NGVT a buy or a sell?, what analysts expect next is on the NGVT forecast, and what the company does is on the Ingevity Corporation (NGVT) stock page.

Every number on this page can be traced to a document Ingevity published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.